• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • Advanced ERC Grant OMVac
    • Advanced ERC Grant vAMRes
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • Orphan diseases
  • Stories
Enter any keyword and press enter

NIBIT Foundation

  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies

NIBIT Foundation

NIBIT, the Italian Network for Cancer Biotherapy, is a non-profit organization representing more than 150 official members from over 40 Italian academic, regulatory and industrial groups/organizations. The Network was formed in 2014 to create a cooperative network that would group and coordinate the activities of the various groups that are working on cancer biotherapy in Italy, given the high number of studies regarding the use of innovative approaches in oncology, and in consideration of the increasing number of institutions and professionals involved.

NIBIT is a member of the World Immunotherapy Council, an international forum to facilitate high-level scientific cooperation in the field of cancer immunology and immunotherapy. Cancer Immunology Immunotherapy is the official scientific journal of NIBIT.


The main activities are:

  • To promote and enhance the scientific and operational interactions among professionals from academia, the biotech/pharmaceutical industry, and regulatory agencies;
  • To promote initiatives to inform patients on cancer bioimmunotherapy and the clinical trials currently available;
  • To train physicians about the potential and limits of cancer bio-immunotherapy, and the available clinical trials:
  • To develop innovative multi-center cancer bio-immunotherapy clinical trials at the national level.


Primary educational and scientific events:

  • National Masters in Immuno-oncology;
  • Regional courses on cancer bio-immunotherapy;
  • "Cancer Bio-Immunotherapy in Siena - the NIBIT Meeting" annual international meeting.


A foundation called “Fondazione NIBIT” was established on the initiative of "NIBIT" in 2012, and aims to carry out scientific and research activities in the biomedical oncological sector, with particular but not exclusive regard to applied research in the pre-clinical and clinical fields in cancer biotherapy. The president of the NIBIT Foundation is Dr. Michele Maio, head of the Oncological Immunotherapy Unit at the Siena University Hospital.


www.nibit.org

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

Segui il webinar, realizzato nell'ambito del progetto regionale "Orienta il tuo futuro", dedicato alle scienze dell…

@FondazioneTLS 17 Hours Ago

C'è ancora tempo fino al 3 marzo per iscriversi al corso Biomedtech20 di @itsvitatoscana e diventare un esperto nel…

@FondazioneTLS 18 Hours Ago

Il @ComuneVeduggio intervista Claudia Sala, ricercatrice veduggese di Tls e vincitrice del Premio Beato Talamoni. P…

@FondazioneTLS 2 Days Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2019 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy